AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
Summary
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
Description
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source